Sigilon, Inc. logo

Sigilon, Inc.

Sigilon’s Living Therapeutics act as cell factories that can be programmed to control dynamic protein delivery (e.g. enzymes, factors and antibodies). This allows for the long-term treatment of debilitating diseases without the need for immune suppression that is traditionally associated with allogeneic cell therapies.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://sigilon.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
100 Binney St, STE 600, MA 02142
Cambridge
United States
Email
Contact Number
+1 617-336-7540

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/sigilon-inc.” connections=”true” suffix=””]